Importantly, although not statistically significant, the serum levels of these molecules (sFlt-1, sFlt-1/PlGF, sEng, sB7-H4) demonstrated a decreasing trend in the PE + TPE patients as compared to the PE patients who received standard-of-care treatment ( Table 1 ). 2.2.
← all excerpts
Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients.
1
—
—